The India molecular diagnostics market size was estimated at USD 1,054.80 million in 2024 and is projected to reach USD 1,717.27 million by 2033, growing at a CAGR of 5.63% from 2025 to 2033. The growth is attributed to an ever-increasing burden of infectious diseases, heightened awarene... Read More »
November 2025The global multiplex testing reagents market size was estimated at USD 1.42 billion in 2024 and is expected to reach USD 4.15 billion by 2033, growing at a CAGR of 13.08% from 2025 to 2033. Multiplex testing reagents enable the simultaneous detection of multiple analytes in a single test... Read More »
November 2025The global imaging biomarkers market size was estimated at USD 13.95 billion in 2024 and is projected to reach USD 39.23 billion by 2033, growing at a CAGR of 12.62% from 2025 to 2033. The growth of the market can be attributed to the increasing burden of chronic diseases such as cancer,... Read More »
October 2025The global nucleic acid amplification testing market size was estimated at USD 9,956.82 million in 2024 and is projected to reach USD 23,146.69 million by 2033, growing at a CAGR of 9.30% from 2025 to 2033. This growth is primarily driven by several key factors, including the rising prev... Read More »
October 2025The global transplant diagnostics market size was estimated at USD 6.39 billion in 2024 and is expected to reach USD 12.15 billion in 2033, growing at a CAGR of 7.45% from 2025 to 2033. The rising prevalence of genetic disorders, technological advancements in genetic testing, and growing... Read More »
October 2025The Middle East advanced cancer diagnostics market size was estimated at USD 1.32 billion in 2024 and is projected to reach USD 2.51 billion by 2030, growing at a CAGR of 7.30% from 2025 to 2033. The market for advanced cancer diagnostics in the Middle East is driven by several strong fa... Read More »
October 2025The global skin cancer diagnostics market size was estimated at USD 9.58 billion in 2024 and is projected to reach USD 15.67 billion by 2033, growing at a CAGR of 5.7% from 2025 to 2033. The integration of artificial intelligence, technological advancements, and patient preference for no... Read More »
October 2025The global cancer and tumor biomarker-based assay market size was estimated at USD 10.97 billion in 2024 and is projected to reach USD 26.81 billion by 2033, growing at a CAGR of 10.50% from 2025 to 2033, driven by the growing demand for early diagnosis, personalized treatment, and preci... Read More »
October 2025The global preeclampsia market size was valued at USD 1.25 billion in 2024 and is expected to reach USD 2.73 billion by 2033, growing at a CAGR of 9.12% from 2025 to 2033. The market is driven by rising incidences of the preeclampsia and the rising demand for early and accurate diagnosti... Read More »
October 2025The U.S. renal biomarkers market size was estimated at USD 592.95 million in 2024 and is projected to reach USD 1,207.75 million by 2033, growing at a CAGR of 8.4% from 2025 to 2033. The rising prevalence of kidney disease, particularly chronic kidney disease (CKD) and acute kidney injur... Read More »
October 2025The Middle East syphilis testing market size was estimated at USD 21.25 million in 2024 and is projected to reach USD 55.01 million by 2033, growing at a CAGR of 11.47% from 2025 to 2033. Growing public health awareness and government-led initiatives are driving demand for syphilis diagn... Read More »
October 2025The global renal biomarkers market size was estimated at USD 1,530.0 million in 2024 and is expected to reach USD 3,161.4 million by 2033, growing at a CAGR of 8.54% from 2025 to 2033. The rising prevalence of kidney disease particularly chronic kidney disease (CKD) and acute kidney inju... Read More »
October 2025The global cancer biopsy market size was estimated at USD 32.32 billion in 2024 and is projected to reach USD 65.68 billion by 2033, growing at a CAGR of 8.2% from 2025 to 2033. The market growth is attributed to the increasing prevalence of cancer, which is propelling the need for innov... Read More »
October 2025The global neuroscience antibodies and assays market size was valued at USD 3,723.43 million in 2024 and is expected to reach USD 5,867.03 million, growing at a CAGR of 5.41% from 2025 to 2033. The market is driven by the rising prevalence of neurological and neurodegenerative disorders ... Read More »
October 2025The U.S. blood testing market size was valued at USD 35.90 billion in 2024 and is projected to reach USD 71.41 billion by 2033, growing at a CAGR of 8.1% from 2025 to 2033. The market is primarily driven by the rising prevalence of chronic diseases such as diabetes, cardiovascular condit... Read More »
September 2025The global enzyme immunoassay market size was valued at USD 17.78 billion in 2024 and is projected to reach USD 24.77 billion by 2033, growing at a CAGR of 3.7% from 2025 to 2033. The industry growth can be attributed to the increasing demand for automation in diagnostic tests, increasin... Read More »
September 2025The global neonatal toxicology market size was estimated at USD 280.92 million in 2024 and is projected to reach USD 701.32 million by 2033, growing at a CAGR of 10.73% from 2025 to 2033. This growth is attributed to the increasing incidence of maternal drug use, along with development o... Read More »
September 2025The global non-specific endonucleases market size was valued at USD 362.34 million in 2025 and is expected to reach USD 585.19 million by 2033, growing at a CAGR of 6.27% from 2026 to 2033. This growth is primarily fueled by rising R&D investments in molecular biology and biotechnolo... Read More »
September 2025The Middle East biomarker-based immunoassays market size was estimated at USD 114.23 million in 2024 and is projected to reach USD 159.25 million by 2033, growing at a CAGR of 3.61% from 2025 to 2033. The market growth is driven by the rising global burden of chronic diseases such as can... Read More »
September 2025The global advanced cancer diagnostics market size was estimated at USD 58.30 billion in 2024 and is expected to reach USD 127.07 billion by 2033, expanding at a CAGR of 9.05% from 2025 to 2033. The market is driven by several strong factors. Rising global cancer incidence continues to expand demand for early and pr... Read More »
September 2025